Prevention and treatment of tumor lysis syndrome in the rasburicase era

被引：0
|
作者：
Galardy, P. J. [1 ]
机构：
[1] Mayo Clin, Dept Pediat & Adolescent Med, Div Pediat Hematol Oncol, Rochester, MN USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 159卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [1] Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase
    Alakel, Nael
    Middeke, Jan Moritz
    Schetelig, Johannes
    Bornhaeuser, Martin
    ONCOTARGETS AND THERAPY, 2017, 10 : 597 - 605
  • [2] Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
    Pession, Andrea
    Melchionda, Fraia
    Castellini, Claudia
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 129 - 141
  • [3] Rasburicase for Tumor Lysis Syndrome
    Vishwanathan, Swati
    Arumugarajah, Aravindhan
    Ortega, Luis M.
    Bousamra, Alex
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (01) : E118 - E121
  • [4] Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies
    Wang, LY
    Shih, LY
    Hung, C
    Jou, ST
    Lin, KH
    Yeh, TC
    Lin, SF
    Liang, DC
    ACTA HAEMATOLOGICA, 2006, 115 (1-2) : 35 - 38
  • [5] The value of low, fixed, single dose rasburicase in the prevention and treatment of tumor lysis syndrome.
    Ponnada, Bharadwaj
    Raghuram, Saadvik
    Kotne, Sanketh
    Keechilat, Pavithran
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Is rasburicase needed for prevention of tumor lysis syndrome during treatment of less aggressive hematolymphoid malignancies?
    Zaidi, SZA
    Aljurf, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) : 3430 - 3431
  • [7] Rational use of rasburicase for the treatment and management of tumor lysis syndrome
    Shaikh, Suhail A.
    Marini, Bernard L.
    Hough, Shannon M.
    Perissinotti, Anthony J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (03) : 176 - 184
  • [8] Revised Indication for Hemodiafiltration during the Treatment of Tumor Lysis Syndrome Associated with Pediatric Oncology in the Era of Rasburicase
    Iwahashi, Madoka
    Kobayashi, Kenichiro
    Hamabata, Takayuki
    Kawachi, Sinpei
    Yamagami, Yuji
    Suga, Takenori
    Maihara, Toshiro
    Usami, Ikuya
    Heike, Toshio
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [9] Prevention and treatment of tumor lysis syndrome in the era of recombinant urate oxidase
    Pession, A.
    HEMATOLOGY REPORTS, 2010, 2 (01)
  • [10] Clarifying the role of rasburicase in tumor lysis syndrome
    Sood, Amy R.
    Burry, Lisa D.
    Cheng, Doret K. E.
    PHARMACOTHERAPY, 2007, 27 (01): : 111 - 121
12345